Mersana Therapeutics Inc (MRSN)
2.38
-0.09
(-3.64%)
USD |
NASDAQ |
May 24, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Cash from Financing (Quarterly): 5.829M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.829M |
| December 31, 2023 | 0.092M |
| September 30, 2023 | -0.146M |
| June 30, 2023 | 73.18M |
| March 31, 2023 | 21.55M |
| December 31, 2022 | 41.46M |
| September 30, 2022 | 10.64M |
| June 30, 2022 | 40.53M |
| March 31, 2022 | 60.39M |
| December 31, 2021 | 28.80M |
| September 30, 2021 | 0.463M |
| June 30, 2021 | 33.92M |
| March 31, 2021 | 0.472M |
| December 31, 2020 | 1.665M |
| September 30, 2020 | -0.049M |
| June 30, 2020 | 228.89M |
| March 31, 2020 | -0.09M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.231M |
| September 30, 2019 | -0.008M |
| June 30, 2019 | 5.277M |
| March 31, 2019 | 92.20M |
| December 31, 2018 | 0.211M |
| September 30, 2018 | 0.209M |
| June 30, 2018 | 0.389M |
| March 31, 2018 | 0.255M |
| December 31, 2017 | 0.021M |
| September 30, 2017 | 70.64M |
| June 30, 2017 | -1.664M |
| March 31, 2017 | -0.401M |
| December 31, 2016 | 0.024M |
| September 30, 2016 | -0.037M |
| June 30, 2016 | 58.24M |
| March 31, 2016 | 0.031M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.146M
Minimum
Sep 2023
228.89M
Maximum
Jun 2020
27.65M
Average
5.553M
Median
Cash from Financing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -13.31M |
| Geron Corp | 147.80M |
| Insmed Inc | 3.022M |
| Altimmune Inc | -0.261M |
| InfuSystems Holdings Inc | 0.632M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.66M |
| Cash from Investing (Quarterly) | -72.55M |
| Free Cash Flow | -173.92M |
| Free Cash Flow Per Share (Quarterly) | -0.27 |
| Free Cash Flow to Equity (Quarterly) | -32.86M |
| Free Cash Flow Yield | -61.12% |